Lv1
50 积分 2025-01-24 加入
Efficacy and safety of dabrafenib plus trametinib in adults with differentiated thyroid cancer: a randomised, double-blind, placebo-controlled, phase 3 trial
7分钟前
已完结
Trop2-Targeted [18F]AlF-RESCA-RT4 ImmunoPET/CT in Guiding Clinical Surgeries of Thyroid Cancers: A Proof-of-Concept Study
1个月前
已完结
Trop2-Targeted [18F]AlF-RESCA-RT4 ImmunoPET/CT in Guiding Clinical Surgeries of Thyroid Cancers: A Proof-of-Concept Study
1个月前
已完结
重组人促甲状腺素介导分化型甲状腺癌的131I治疗
1年前
已完结
头颈鳞癌KEYNOTE-689 Ⅲ期临床试验解读与启示
1年前
已关闭
Cancer of Unknown Primary Site
1年前
已完结
Treatment with hydrogen molecules prevents RANKL-induced osteoclast differentiation associated with inhibition of ROS formation and inactivation of MAPK, AKT and NF-kappa B pathways in murine RAW264.7 cells
皖公网安备34019202002308
